← EPO Patent Bulletin

COMBINATION THERAPIES COMPRISING A SOS1 INHIBITOR AND AN EGFR INHIBITOR

Publication EP4504171A2 Kind: A2 Mar 18, 2026

Applicants

Mirati Therapeutics, Inc.

Inventors

HALING, Jacob, KHARE, Shilpi

IPC Classifications

A61K 31/5377 20060101AFI20260210BHEP A61K 31/517 20060101ALI20260210BHEP A61K 31/395 20060101ALI20260210BHEP A61K 31/16 20060101ALI20260210BHEP A61K 31/407 20060101ALI20260210BHEP A61K 31/33 20060101ALI20260210BHEP A61K 31/506 20060101ALI20260210BHEP A61K 45/06 20060101ALI20260210BHEP A61P 35/00 20060101ALI20260210BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR